Publications by authors named "Thomas D Giles"

Claim this Profile
B
Blood pressure is a beautiful (but imperfect) biomarker of hypertension. The quixotic quest that fuels the hypertension guideline industry.
Thomas D Giles, John B Kostis, Camilo Fernandez

J Clin Hypertens (Greenwich)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of decreases in systemic arterial pressure and heart rate in response to the hydrogen sulfide donor sodium sulfide.
Kevin W Swan, Bryant M Song, Allen L Chen, Travis J Chen, Ryan A Chan, Thomas D Giles

Am J Physiol Heart Circ Physiol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.
Thomas D Giles, John R Cockcroft, Bertram Pitt, Abhijeet Jakate, Harold M Wright

J Hypertens· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of nebivolol-valsartan single-pill combination in obese and nonobese patients with hypertension.
Christian W Mende, Thomas D Giles, David B Bharucha, William G Ferguson, Madhuja Mallick

J Clin Hypertens (Greenwich)· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodological evaluation of the noninvasive estimation of central systolic blood pressure in nontreated patients: the Bogalusa Heart Study.
Camilo Fernandez, Robert Hsu, Gary Sander, Azad Hussain, Rupert Barshop, Thomas D Giles

Blood Press Monit· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoproteins and Blood Pressure: A Story of Evolution in Biomarker Analysis.
Camilo Fernandez, Alexander Romero, Thomas D Giles

J Am Coll Cardiol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension.
Gary E Sander, Camilo Fernandez, Thomas D Giles

Expert Rev Cardiovasc Ther· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nebivolol has a beneficial effect in monocrotaline-induced pulmonary hypertension.
Edward A Pankey, Justin A Edward, Kevin W Swan, Camille R T Bourgeois, Matthew J Bartow, Thomas D Giles

Can J Physiol Pharmacol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prehypertension: Defining the Transitional Phenotype.
Camilo Fernandez, Gary E Sander, Thomas D Giles

Curr Hypertens Rep· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension.
Thomas D Giles, George Bakris, Suzanne Oparil, Michael A Weber, Huiling Li

J Am Soc Hypertens· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial Progenitor Cells as a Biomarker for Transitional Phenotypes in Hypertension.
Thomas D Giles, Gary E Sander

J Clin Hypertens (Greenwich)· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apathy towards ambulatory blood pressure monitoring use in hypertension: is it due to cognitive dissonance, money, or both?
Thomas D Giles

Hypertension· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension.
Gary E Sander, Thomas D Giles

Expert Opin Pharmacother· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital plethysmography and arginine metabolism in prehypertension: effect of nebivolol therapy.
Ramprasad Kandavar, Camilo Fernandez, Gary E Sander, Catherine Kim, Santhosh Velaga, Thomas D Giles

J Clin Hypertens (Greenwich)· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study.
Joel M Neutel, Thomas D Giles, Henry Punzi, Robert J Weiss, Huiling Li

J Am Soc Hypertens· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular stiffness is a biomarker of global cardiovascular risk.
Gary E Sander, Thomas D Giles

J Clin Hypertens (Greenwich)· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASH hypertension self-assessment program.
Thomas D Giles

J Am Soc Hypertens· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
Thomas D Giles, Michael A Weber, Jan Basile, Alan H Gradman, David B Bharucha

Lancet· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertension 101: the place to start.
Thomas D Giles

J Clin Hypertens (Greenwich)· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter-arm difference in systolic blood pressure-"the plot stiffens"-.
Thomas D Giles

J Clin Hypertens (Greenwich)· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
Roberto Latini, Lidia Staszewsky, Jie-Lena Sun, M Angelyn Bethel, Marcello Disertori, Thomas D Giles

Am Heart J· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
David Preiss, Thomas D Giles, Laine E Thomas, Jie-Lena Sun, Steven M Haffner

Stroke· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nebivolol monotherapy in younger adults (younger than 55 years) with hypertension: a randomized, placebo-controlled trial.
Thomas D Giles, Bobby V Khan, June Lato, Lillian Brener, Yimin Ma

J Clin Hypertens (Greenwich)· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale for establishing a mechanism to increase reimbursement to hypertension specialists.
William J Elliott, Brent Egan, Thomas D Giles, George L Bakris, William B White

J Clin Hypertens (Greenwich)· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diastolic blood pressure and hypertension phenotypes: the US Food and Drug Administration has it right.
Thomas D Giles, Gary E Sander

J Clin Hypertens (Greenwich)· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis